Contact
Diario Médico interviews Travis Stracker, who has recently left the Memorial Sloan Kettering Cancer Center of New York to set up in Genomic Instability and Cancer Lab at IRB Barcelona.
The North-American scientist explains the research lines that he will start in his new lab. Among these, special mention is given to the study of the MRE-11 complex, a DNA repair pathway associated with enhanced chemosensitivity of lymphomas.
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
